MedTrace Logo

Prospective Analysis of Septic Associated Encephalopathy Using the Non-invasive Acoustocerebrography-ACG

NCT03173196 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2017-08-14

No results posted yet for this study

Summary

The patients of the group "sepsis" are measured several times with the non-invasive multi-spectral sonography (Sonovum "ACG-Diagnosesystem") (days 1, 3, 7 and 14). The patients of the group "control" are measured on days 1 and 3 with the system. A measurement takes 3 minutes. For this purpose two ultrasound heads are placed above the patient's ears and fixed with an all-head harness. The device is certified for CE application. There are no known health risks of ultrasound in humans.

Conditions

  • Encephalopathy
  • Organ Dysfunction Syndrome

Interventions

DEVICE

Non-invasive Multispectral Sonography

We measure both groups wirh the non-invasive multispectral sonography for 3 and for 30 minutes.

Sponsors & Collaborators

  • University of Rostock

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-01
Primary Completion
2017-07-10
Completion
2017-07-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03173196 on ClinicalTrials.gov